title: A simple immunohistochemical panel comprising 2 conventional markers, Ki67 and p53, is a powerful tool for predicting patient outcome in luminal-type breast cancer.
abstract: BACKGROUND
  Ki67 is widely used in order to distinguish the "A" and "B" subtypes of luminal-type breast cancer. This study aimed to validate the prognostic value of adding p53 to Ki67 for characterizing luminal-type breast cancer.
  
  
  METHODS
  Immunostaining for Ki67, p53, and the molecular markers HER2, CK5/6, CK14, EGFR, FOXA1, GATA3, and P-cadherin was examined hormone receptor (HR)-positive cancer tissues from 150 patients. The prognostic value of an immunohistochemical panel comprising Ki67 and p53 was compared with that of the single Ki67 labeling index (LI), and uni- and multivariate analyses were performed.
  
  
  RESULTS
  Division of the patients based on the immunohistochemistry results into favorable- (low Ki67 LI, p53-negative) and unfavorable- (high Ki67 LI and/or p53-positive) phenotype groups yielded distinctly different Kaplan-Meier's curves of both disease-free (P<0.0001) and overall survival (P=0.0007). These differences were much more distinct than those between the corresponding low Ki67 LI vs. high Ki67LI curves. While the prognostic values of the other molecular markers were not significant, combined Ki67-p53 status was an independent prognostic factor by multivariate analysis.
  
  
  CONCLUSIONS
  These data indicate that an immunohistochemical panel comprising Ki67 and p53 is a practical tool for management of patients with HR-positive breast cancer.
authors: Department of Basic Pathology, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan. tkobayashi.g@gmail.com.
authors: Takayuki
authors: T
authors: Kobayashi
authors: Keiichi
authors: K
authors: Iwaya
authors: Tomoyuki
authors: T
authors: Moriya
authors: Tamio
authors: T
authors: Yamasaki
authors: Hitoshi
authors: H
authors: Tsuda
authors: Junji
authors: J
authors: Yamamoto
authors: Osamu
authors: O
authors: Matsubara
references: Breast Cancer Res. 2008;10(5):R74
references: 18771580
references: N Engl J Med. 2004 Dec 30;351(27):2817-26
references: 15591335
references: J Clin Pathol. 2008 Mar;61(3):327-32
references: 18037662
references: Lancet. 2004 Sep 4-10;364(9437):858-68
references: 15351193
references: J Clin Oncol. 2006 Aug 10;24(23):3726-34
references: 16720680
references: J Clin Oncol. 2006 Jul 1;24(19):3039-47
references: 16809728
references: Breast Cancer Res. 2008;10(4):R65
references: 18662380
references: Clin Cancer Res. 2008 Dec 15;14(24):8010-8
references: 19088017
references: Breast Cancer Res Treat. 2008 Sep;111(1):27-44
references: 17922188
references: J Natl Cancer Inst. 2006 Sep 20;98(18):1285-91
references: 16985247
references: Breast Cancer Res Treat. 2010 Oct;123(3):733-45
references: 20020198
references: Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74
references: 11553815
references: J Clin Oncol. 2007 Jan 1;25(1):118-45
references: 17159189
references: Virchows Arch. 2005 Oct;447(4):688-94
references: 16012853
references: JAMA. 2006 Jun 7;295(21):2492-502
references: 16757721
references: BMC Genomics. 2006 Apr 27;7:96
references: 16643655
references: N Engl J Med. 1998 Oct 1;339(14):974-84
references: 9753714
references: Clin Cancer Res. 2008 Oct 15;14(20):6602-9
references: 18927301
references: Jpn J Cancer Res. 1991 Jul;82(7):835-40
references: 1679056
references: Br J Cancer. 2011 Jul 12;105(2):272-80
references: 21712826
references: Ann Oncol. 2012 Dec;23(12):3069-3074
references: 22674146
references: J Clin Pathol. 2009 Jan;62(1):6-12
references: 18794199
references: J Natl Cancer Inst. 2009 May 20;101(10):736-50
references: 19436038
references: Clin Cancer Res. 2006 Feb 15;12(4):1157-67
references: 16489069
references: Histopathology. 2002 Jan;40(1):2-11
references: 11903593
references: Lancet. 1998 May 16;351(9114):1451-67
references: 9605801
references: Breast Cancer Res. 2006;8(4):R34
references: 16846532
references: Lancet Oncol. 2010 Feb;11(2):174-83
references: 20152769
references: Pathology. 2005 Feb;37(1):45-50
references: 15875733
references: J Clin Oncol. 2008 Dec 1;26(34):5569-75
references: 18981464
references: Endocr Relat Cancer. 2006 Jun;13(2):293-325
references: 16728565
references: J Clin Oncol. 2005 Oct 10;23(29):7350-60
references: 16145060
references: N Engl J Med. 2001 Mar 15;344(11):783-92
references: 11248153
references: Clin Cancer Res. 2011 Dec 15;17(24):7828-34
references: 21998336
references: J Clin Oncol. 2011 Sep 1;29(25):3366-73
references: 21768458
references: Clin Cancer Res. 1996 Jan;2(1):147-54
references: 9816101
references: Breast Cancer. 2005;12 Suppl:S1-27
references: 16410755
references: Breast Cancer Res. 2009;11(2):R23
references: 19405945